Chromogranin A as a useful neuroendocrine marker in patients with autoimmune Addison's disease

Journal of Endocrinological Investigation

Volumn 33, Issue 3, 2010, Pages 186-191

  El Ali, Z ^a   Fichna, M ^a   Piniewska, J ^a   Kosowicz, J ^a   Grzymistawski, M ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Addison's disease; Antiparietal cells antibodies; Chromogranin A

Indexed keywords

BIOLOGICAL MARKER; CHROMOGRANIN A; CORTISONE DERIVATIVE; FLUOROCORTISONE ACETATE; GASTRIN; HYDROCORTISONE; PARIETAL CELL ANTIBODY; UNCLASSIFIED DRUG;

ADDISON DISEASE; ADULT; AGED; ANTIBODY BLOOD LEVEL; ARTICLE; AUTOIMMUNE DISEASE; CELL HYPERPLASIA; CLINICAL ARTICLE; CORRELATION ANALYSIS; DIAGNOSTIC VALUE; DYSPLASIA; EARLY DIAGNOSIS; ENDOCRINE DISEASE; ENTEROCHROMAFFIN LIKE CELL; FEMALE; HIGH RISK PATIENT; HORMONE BLOOD LEVEL; HUMAN; HYPERCHROMOGRANINEMIA; HYPERGASTRINEMIA; MALE; NEUROENDOCRINE SYSTEM; STOMACH CARCINOID;

ADDISON DISEASE; ADULT; AGED; AUTOIMMUNE DISEASES; BIOLOGICAL MARKERS; CHROMOGRANIN A; ENTEROCHROMAFFIN-LIKE CELLS; FEMALE; GASTRINS; HUMANS; HYPERPLASIA; MALE; MIDDLE AGED; PARIETAL CELLS, GASTRIC;

EID: 77952844238     PISSN: 03914097     EISSN: 17208386     Source Type: Journal    
DOI: 10.1007/bf03346579     Document Type: Article

References (14)

1. Nobels FR, Kwekkeboom DJ, Bouillon R, Lamberts SW. Chromogranin A: its clinical value as marker of neuroendocrine tumours. Eur J Clin Invest 1998, 28: 431-440 (Pubitemid 28326407)
2. Taupenot L, Harper KL, O'Connor DT. The chromogranin-secretogranin family. N Engl J Med 2003, 348: 1134-1149
3. Arlt W, Allolio B. Adrenal insufficiency. Lancet 2003, 361: 1881-1893
4. Bednarek J, Furmaniak J, Wedlock N, et al. Steroid 21-hydroxylase is a major autoantigen involved in adult onset autoimmune Addison's disease. FEBS Lett 1992, 309: 51-55
5. Seissler J, Schott M, Steinbrenner H, Peterson P, Scherbaum WA. Autoantibodies to adrenal cytochrome P450 antigens in isolated Addison's disease and autoimmune polyendocrine syndrome type II. Exp Clin Endocrinol Diabetes 1999, 107: 208-213 (Pubitemid 29240216)
6. Borch K, Stridsberg M, Burman P, Rehfeld JF. Basal chromogranin A and gastrin concentrations in circulation correlate to endocrine cell proliferation in type-A gastritis. Scand J Gastroenterol 1997, 32: 198-202. (Pubitemid 27105292)
7. Betterle C, Lazzarotto F, Presotto F. Autoimmune polyglandular syndrome Type 2: the tip of an iceberg?. Clin Exp Immunol 2004, 137: 225-233 (Pubitemid 39013066)
8. Zelissen PM, Bast EJ, Croughs RJ. Associated autoimmunity in Addison's disease. J Autoimmun 1995, 8: 121-130
9. Kulke MH, Mayer RJ. Carcinoid tumors. N Engl J Med 1999, 340: 858-868
10. Peghini PL, Annibale B, Azzoni C, et al. Effect of chronic hypergastrinemia on human enterochromaffin-like cells: insights from patients with sporadic gastrinomas. Gastroenterology 2002, 123: 68-85. (Pubitemid 34747527)
11. De Block CE, Colpin G, Thielemans K, et al. Neuroendocrine tumor markers and enterochromaffin-like cell hyper/dysplasia in type 1 diabetes. Diabetes Care 2004, 27: 1387-1393 (Pubitemid 38679988)
12. Capellino S, Lowin T, Angele P, Falk W, Grifka J, Straub RH. Increased chromogranin A levels indicate sympathetic hyperactivity in patients with rheumatoid arthritis and systemic lupus erythematosus. J Rheumatol 2008, 35: 91-99
13. Peracchi M, Gebbia C, Basilisco G, et al. Plasma chromogranin A in patients with autoimmune chronic atrophic gastritis, enterochromaffin-like cell lesions and gastric carcinoids. Eur J Endocrinol 2005, 152: 443-448 (Pubitemid 40439498)
14. Nobels FR, Kwekkeboom DJ, Coopmans W, et al. A comparison between the diagnostic value of gonadotropins, alphasubunit, and chromogranin-A and their response to thyrotropin-releasing hormone in clinically nonfunctioning, alpha-subunit-secreting, and gonadotroph pituitary adenomas. J Clin Endocrinol Metab 1993, 77: 784-789 (Pubitemid 23298667)